Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. - Wikidata - wikimedia - TriplyDB

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.

http://www.wikidata.org/entity/Q33754533

about

[Procalcitonin as a tool for the assessment of successful therapy of severe sepsis : An analysis using clinical routine data].Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.Using Procalcitonin to Guide Antibiotic Therapy.Monitoring treatment response in abdominal sepsis with procalcitonin--if only!Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study.Year in review 2013: Critical Care--sepsis.Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections.Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis.Procalcitonin Kinetics in the First 72 Hours Predicts 30-Day Mortality in Severely Ill Septic Patients Admitted to an Intermediate Care Unit The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study Procalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis.Rapid diagnosis of sepsis.The management of severe community acquired pneumonia in the intensive care unit.The bacterial pneumonias: a new treatment paradigm.Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study.Determining the Clinical Utility of an Absolute Procalcitonin Value for Predicting a Positive Culture Result.Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit.Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis.Procalcitonin: The right answer but to which question?Cell-free DNA increase over first 48 hours in emergency intensive care unit predicts fatal outcome in patients with shock.Use of procalcitonin, C-reactive protein and white blood cell count to distinguish between lower limb erysipelas and deep vein thrombosis in the emergency department: A prospective observational study.Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trial.Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study.Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).Expression of CD64 on neutrophils can be used to predict the severity of bloodstream infection before broad range 16S rRNA PCR.Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia.Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients.Effect of interleukin-31 on septic shock through regulating inflammasomes and interleukin-1β.Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis

P2860

Q31112286-F890359B-6DBF-4B99-9B6C-CDF03389A9D5 Q33557838-C32887BC-957E-4E63-B42B-431E651CF363 Q33629591-0EC810B5-BBF4-4E5F-B686-C61033E3A3D8 Q33752801-09C7F2B2-72BE-4C98-A549-425682A44D74 Q33753353-45A65E54-FCAC-4F80-B756-37E0810151F6 Q34271299-E5A7972E-8D93-45BD-939E-F9BC5E1535CC Q34500700-D0B73C87-15CB-46D6-93ED-F8B4CCDA0B33 Q34612152-DA6B97AE-D0B5-40D3-A25D-E7D61E2F8582 Q35091080-FF00AAE5-03E6-47E9-B6C6-3D8BD864E32D Q35156585-CF29F61F-C27D-4BE8-BAB7-7F0704289623 Q35226677-CD93B172-5032-4BD1-90A9-526BF3B8D977 Q35234151-B9C2AF36-D672-42A8-8A69-0B3DD1E64F1A Q35663942-E99BE040-1471-42C7-837F-A797D92D5505 Q35910746-C5289640-A981-4130-ADE6-36B1AC436BF4 Q36131387-867BAEB4-1968-4E59-BCD5-571DDFC82D1C Q36222704-904D6A88-76C3-45FF-8C88-BC431E7B51C8 Q37639927-B305A59F-325A-4D6F-B20B-F0CE44CC2C1C Q38171058-CBB9C200-6A10-46FD-B10F-05AA8A7C7704 Q38212536-5C2ACED2-926F-491E-A013-84FF46524109 Q38307688-A165D9D0-D5E3-49E0-AE52-86D979D85318 Q38545824-3838167C-8E95-4BC6-B9F7-D22B62B5A02A Q38963373-BEC41598-A1B4-46ED-8C8B-C1D5CF87233C Q40074249-404E224E-46CD-49CF-87CA-F1208682B4BA Q40237535-D7B1141E-1D33-4E72-9D83-ED93AA423F7A Q40252197-8F326B1D-69B4-4514-BB11-0A51C4E14E6B Q40662992-D0793FDC-5254-4251-A3FA-2563BD836FEF Q40931324-ADB9C412-15FE-4710-B30A-78D52E3410D3 Q40970863-2D4C66B3-F49C-4E26-A097-F0EFAB09CD13 Q41016892-434E887E-B1CF-472F-A42F-7FE97859FF0D Q41099789-25B0338E-4C53-4573-A8E8-31E523A2B28D Q41727236-9E4A93C1-0481-44B6-B062-4269BD91A2F6 Q41893491-783B2F01-8ED0-4BA4-8905-2559DEA23F9F Q52611408-6C2AEA77-1912-4D79-8951-F4B83938119A Q55296740-881868EE-2924-4269-AF45-1B107046F49C Q58763790-33A03D2C-590B-4677-A482-26824313BF31 Q58779035-D7E79216-F7BD-45B0-B698-093108F64176 Q59127229-27013920-9484-47A2-94FD-A307F3CF4203

P2860

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.

http://www.wikidata.org/entity/Q33754533

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@ast

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@en

type

label

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@ast

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@en

prefLabel

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@ast

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@en

P1433

Q33754533-3E22687E-1643-48D7-A7FF-80032E1B1A36

P1476

Q33754533-746BD45C-C764-4E15-A936-4945BBDD9377

P2093

Q33754533-444D88D5-A612-4797-A379-F82928779308

Q33754533-5ADBFCE6-0AC5-4D6D-9F6C-D0310B5FB4F2

Q33754533-6F120089-188F-4260-9690-9EB30F69F95E

Q33754533-84CDB480-0CA5-43CF-B3BF-13095B85B8D4

Q33754533-A810B5E5-6049-4A68-889A-8CD2D26B60CE

Q33754533-D8190AF3-498F-4A8D-BB9A-EA915BDD6AEB

P2860

Q33754533-0D5603AC-6856-4986-B2D8-35A9C30741F5

Q33754533-1B6B1A0D-91DC-4D45-8517-860E98B07CA6

Q33754533-1CE68981-1BDE-4F89-8219-C32D4ADD4B62

Q33754533-266C9AA4-D342-427D-9A2D-C520E9411C06

Q33754533-27A43950-2790-4CC7-B5C1-B45553276699

Q33754533-3034CBCB-CE10-4AA4-89BD-BDAED1533A30

Q33754533-3FB364E7-74C3-41FD-9C90-A8118FF865A3

Q33754533-544426C7-0F07-4E60-B719-71E0817B83A0

Q33754533-58A04766-55C1-47DB-91D1-418703B1BA14

Q33754533-6867845C-73C8-406F-9320-7C251081BCAE

P2888

Q33754533-86114B47-5718-4B76-87AB-16BA388B18B9

P304

Q33754533-E3FEC237-CC6D-4D38-9371-6316A7D69F72

P31

Q33754533-1DA07C46-DFF9-4533-AA53-CBAD06CE0572

P356

Q33754533-F396F0EB-4D23-4B51-B1A1-B3F43BC64357

P433

Q33754533-584D8CFA-36CB-402B-BF91-EB12FDF215C4

P478

Q33754533-7A33C56F-6BEE-4D19-8C42-130BB066BA6D

P577

Q33754533-85E1FC24-8524-4CC7-9FA2-3C9058DB41F7

P5875

Q33754533-DD261B3C-5C18-4560-87C2-A17CC72C4DC4

P6179

Q33754533-42CD5FD9-8960-4C28-8D1C-C26E9B7CC25A

P698

Q33754533-E01AD0FE-77CD-4AAC-978A-4B1E985C2075

P921

Q33754533-9C33A463-F97C-4B68-B67C-DB4563B83F03

P932

Q33754533-9FF5FCC4-E6AA-406E-9A7B-E1EE31F78821

P356

P1433

P1476

Procalcitonin decrease over 72 ...... al outcome in sepsis patients.

@en

P2093

Ami Desai

http://www.w3.org/2001/XMLSchema#string

Devendra N Amin

http://www.w3.org/2001/XMLSchema#string

Eric Gluck

http://www.w3.org/2001/XMLSchema#string

Paula Maurer

http://www.w3.org/2001/XMLSchema#string

Philipp Schuetz

http://www.w3.org/2001/XMLSchema#string

Vikas Punjabi

http://www.w3.org/2001/XMLSchema#string

P2860

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.

Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

P2888

P304

R115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC12787

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240308593

http://www.w3.org/2001/XMLSchema#string

P6179

1022151447

http://www.w3.org/2001/XMLSchema#string

P698

23787145

http://www.w3.org/2001/XMLSchema#string

P921

P932

4057444

http://www.w3.org/2001/XMLSchema#string